“Deucravacitinib in Moderate Plaque Psoriasis: Efficacy in the Phase 3 POETYK PSO-1 and PSO-2 Trials ”, J of Skin, vol. 8, no. 2, p. s364, Mar. 2024, doi: 10.25251/skin.8.supp.364.